New Jersey employers have finally received a roadmap from the state on marijuana in the workplace. Late last week the Cannabis Regulatory Commission issued the long-awaited guidance as a first step toward the development of permanent standards outlining how businesses should respond if a worker is impaired due to marijuana. A key recommendation says employers can, but aren’t required to, use so-called Workplace Impairment Recognition Experts, or WIREs, when determining if an employee is high at work.
Cannabis Regulatory Commission
The law aims to give those with past marijuana convictions first dibs in the licensing process to open up a sales location.
Not only does Caban have convictions in his past, the Camden native was raised and still lives in an impact zone, defined by the state Cannabis Regulatory Commission as an economically challenged area marked by high unemployment and poverty, and disproportionately affected by the nation’s War on Drugs.
he New Jersey Cannabis Regulatory Commission (NJ-CRC) announced the workplace guidelines during a meeting on Friday, joining several other states that have implemented specific protections for people who use marijuana in compliance with state law.
The CRC says that workers have the right to use marijuana on their off-time but adds that businesses also have the right to keep a drug-free workplace.
“Employers have the right to maintain a drug-free workplace…Employers may require an employee to undergo a drug test upon reasonable suspicion of an employee’s usage of cannabis or cannabis products…” the CRC wrote in its guidance.
In a 3-2 vote on last week, the state's Cannabis Regulatory Commission voted for the sales expansion of Ascend Wellness in Fort Lee, NJ Advance Media reports.
In August, the company began selling recreational marijuana out of its Montclair location, and its Rochelle Park began doing so in April.
A positive drug test combined with documented signs of impairment might be enough for an employer to fire or reprimand a worker who is high on the job, according to guidelines released Friday by the state panel overseeing cannabis.
But a scientifically reliable test showing cannabis in the worker’s body on its own is insufficient to support adverse employment action, the guidelines say.
New Jersey Cannabis Regulatory Commission (NJ-CRC) officials are touting a new user-friendly, comprehensive platform debuting on Sept. 12, noting it enables patients to better manage their care.
Exclusive documents obtained by Bloomberg under New Jersey’s Open Public Records Act show that the state cannabis regulatory commission issued citations to seven companies from January 2020 through mid-April 2022, when marijuana sales broadened from medical to recreational. There were a total of 54 alleged violations.
Excerpt from public documents on New Jersey cannabis citations.
Curaleaf is expected to go before a state panel in two weeks to obtain final approvals to expand its 1 ½-year old medical dispensary in Bordentown Township and begin selling adult recreational weed.
If the New Jersey Cannabis Regulatory Commission gives approval at its Sept. 9 meeting, a Bordentown Township official anticipates adult weed sales to commence soon after at the Curaleaf medical cannabis dispensary located at 191 U.S. 130 North.
In the continuing growth of the retail cannabis business in Jersey City, the council (with Councilman Rich Boggiano absent) unanimously gave their support to four retail cannabis applicants.
The four are Ufoira at 138 Griffith St. in the Heights, Jersey Leaf at 554 West Side Ave. on the West Side, Butler & Baldwin at 75 Martin Luther King Drive in Greenville, and Decades Dispensary at 404 Central Ave., also in the Heights.